Background Thrombolytic therapy is effective method in the high-risk acute pulmonary
embolism (PE) treatment. Reduced-dose thrombolysis (RDT) plus oral anticoagulation …

Background The optimal treatment strategy of patients with pulmonary embolism
(PE)(especially those with intermediate risk) continues to evolve and remains controversial …

Dabigatran was non-inferior to warfarin for prevention of recurrent venous thromboembolism
(VTE), and dabigatran had a lower rate of bleeding compared with warfarin in two large …

Background: Intermediate-high risk acute pulmonary embolism (PE) remains associated
with substantial mortality despite anticoagulation therapy. Aims: The aim of this randomised …

Background: Little data exist on the use of direct oral anticoagulant (DOAC) factor Xa
inhibitors for submassive pulmonary embolism (PE) after catheter-directed thrombolysis …

Purpose To examine the safety of therapeutic-dose anticoagulation during catheter-directed
thrombolysis (CDT) for acute pulmonary embolism (PE). Materials and Methods A …

Background Catheter-directed thrombolysis (CDT) is one of the newest treatment options for
submassive pulmonary embolism (sPE). This study will compare the efficacy and safety of …

Background Pulmonary embolism (PE) with cor pulmonale causes considerable mortality
and morbidity. Randomized trials have failed to show a mortality difference between …

Background The effectiveness of catheter-directed thrombolysis (CDT) for acute pulmonary
embolism (PE) has been rarely investigated in subgroups of patients at a higher risk of …

Background Catheter-directed thrombolysis (CDT) can accelerate relief of the right ventricle
overload secondary to acute pulmonary embolism (PE). The effectiveness and safety of …